Mehra MR, Goldstein DJ, Uriel N, et al. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378:1386–95.
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145:e876–94.
Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA. 2022;328:1233–42.
Article PubMed PubMed Central Google Scholar
Bravo CA, Navarro AG, Dhaliwal KK, et al. Right heart failure after left ventricular assist device: from mechanisms to treatments. Front Cardiovasc Med. 2022;9:1023549.
Article PubMed PubMed Central Google Scholar
Scheel PJ 3rd, Giuliano K, Tichnell C, et al. Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience. ESC Heart Fail. 2022;9:1008–17.
Minegishi S, Kinoshita O, Hoshino Y, et al. Long-term support by left ventricular assist device for arrhythmogenic right ventricular cardiomyopathy. Artif Organs. 2019;43:909–12.
Ono M. Continuous-flow left ventricular assist device treatment for arrhythmogenic right ventricular cardiomyopathy complicated by advanced biventricular failure—University of Tokyo experiences. Front Cardiovasc Med. 2022;9:1023191.
Article PubMed PubMed Central Google Scholar
Bonios MJ, Armenis I, Kogerakis N, et al. Phenotype characterization and course of patients with arrhythmogenic right ventricular cardiomyopathy and biventricular advanced heart failure: a report of 3 cases. Transplant Proc. 2022;54:2347–51.
Article CAS PubMed Google Scholar
Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383:736–47.
Saeed Diyar, Feldman David, Banayosy AE, et al. The 2023 international society for heart and lung transplantation guidelines for mechanical circulatory support: a 10- year update. J Heart Lung Transplant. 2023;42:e1–222.
Lin Weiqin, Poh AH, Wilson Tang AH. Novel insights and treatment strategies for right heart failure. Curr Heart Fail Rep. 2018;15:141–55.
Belkin MN, Kagan V, Labuhn C, Pinney SP, Grinstein J. Physiology and clinical utility of HeartMate pump parameters. J Card Fail. 2022;28:845–62.
Benza RL, Langleben D, Hemnes AR, et al. Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2022. https://doi.org/10.1183/16000617.0061-2022.
Article PubMed PubMed Central Google Scholar
Taran IN, Belevskaya AA, Saidova MA, et al. Initial Riociguat monotherapy and transition from sildenafil to riociguat in patients with idiopathic pulmonary arterial hypertension: influence on right heart remodeling and right ventricular-pulmonary arterial coupling. Lung. 2018;196:745–53.
Comments (0)